A PYMNTS Company
Antitrust Chronicle® – Patents and Standard Settings

Antitrust Chronicle® – Patents and Standard Settings

Winter 2016, Volume 1, Number 1

This month, the Antitrust Chronicle® brings you an interesting and complex issue at the crossroads of antitrust and intellectual property rights, the analysis of standard settings. Fair, Reasonable and Non-Discriminatory… the infamous ‘FRAND.’ We see this term time and time again in antitrust policy. None more so than when linked to the issue of standard […]

Read More

In this issue

Antitrust Chronicle® – Patents and Standard Settings
CPI
Sep 15, 2016
CPI Talks: Seminar – The role of Antitrust in licensing disputes in ICT sector, Singapore – April 2016.
CPI
Sep 15, 2016
Standards Setting, Standards Development and Division of the Gains from Standardization
CPI
Sep 15, 2016
FRAND Licensing In Theory And In Practice: Proposal For A Common Framework
Justus Baron
Sep 15, 2016
FRAND Arbitration: The Determination of Fair, Reasonable and Non-Discriminatory Rates for SEPs by Arbitral Tribunals
CPI
Sep 15, 2016
On the Practical Irrelevance and Theoretical Inadequacy of the Royalty-Stacking Benchmark in Standard-Essential Patent Negotiations
CPI
Sep 15, 2016
Antitrust Policy toward Technology Standards
CPI
Sep 15, 2016
Exploiting Others’ Investments in Open Standards
Bradley Tennis
Sep 15, 2016
FRAND and the Smallest Saleable Unit
CPI
Sep 15, 2016
Innovation Under Threat? An Assessment of the Evidence for Patent Holdup and Royalty Stacking in SEP-Intensive, IT Industries
CPI
Sep 15, 2016
Special Feature: Why The Supreme Court Should Deny Certioriari In King Drug
CPI
Sep 15, 2016

In case you missed it...

See more Chronicles by year:

Featured News

South Korean Law Firm Lee & Ko Adds Antitrust Partner Min-Ho Lee
Jan 15, 2026 by

Trump Nominates Business Executive and GOP Donor to FTC
Jan 15, 2026 by

OSTP Official Lays Out Details on White House AI Initiatives At House Hearing
Jan 15, 2026 by

Eli Lilly and Novo Nordisk Accused of Blocking Access to Lower-Cost Weight-Loss Drugs
Jan 15, 2026 by

Visa, Mastercard and Revolut Fail to Block UK Fee Cap Proposal
Jan 15, 2026 by